Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.77
Delayed Data
As of Dec 02
 -0.01 / -1.28%
Today’s Change
0.61
Today|||52-Week Range
1.71
-45.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues937.6K2.4M0.000.00
 
 
 
Cost of Goods Sold287.9K530.5K0.000.00
 
 
 
Depreciation And Amortization135.9K312.9K7.9K7.0K
 
 
 
 
 
 
Operating ExpensesGross Income513.8K1.5M-7.9K-7.0K
 
 
 
 
 
General Expenses3.7M3.8M2.0M2.0M
 
 
 
 
 
Research And Development99.0K113.3K274.1K577.8K
 
 
 
 
 
Total Operating Expenses4.1M4.6M2.0M2.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.2M-2.2M-2.0M-2.0M
 
 
 
 
 
Extraordinary Credit794.7K10.0K--0.00
 
 
 
Extraordinary Charge---1.7M---1.6M
 
 
 
Interest Expense On Debt0.000.005.9K9.0K
 
 
 
Equity In Earnings568.8K-847.3K0.000.00
 
 
 
Other Expenses9.0K1.1M-99.6K-12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.3M-2.9M-2.1M-3.6M
 
 
 
 
 
Minority Interest-351.9K-1.2M0.000.00
 
 
 
Discontinued Operations0.000.00-402.2K0.00
 
 
Extraordinary Items0.000.000.00-688.7K
 
 
Net Income-1.4M-2.5M-2.5M-3.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.9M11.2M11.6M13.2M
 
 
 
 
 
Shares To Calculate EPS Diluted10.9M11.2M11.6M13.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.22-$0.22-$0.34
 
 
 
 
 
EPS Diluted-$0.12-$0.22-$0.22-$0.28